| Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I |
89 |
| Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII |
87 |
| Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates |
50 |
| Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5years of treatment (SCULPTURE Extension Study) |
43 |
| Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group |
32 |
| Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response |
24 |
| Isothiazolinone derivatives and allergic contact dermatitis: a review and update |
24 |
| European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas |
23 |
| Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials |
23 |
| Telemedicine in dermatology: findings and experiences worldwide - a systematic literature review |
22 |
| European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo |
22 |
| Multiple switches between GP an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis: 30-week results from the phase confirmatory EGALITY study |
20 |
| Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study |
20 |
| French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults |
19 |
| Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries |
19 |
| Safety of selective IL-23p19 inhibitors for the treatment of psoriasis |
18 |
| Early laser intervention to reduce scar formation - a systematic review |
18 |
| The influence of exposome on acne |
18 |
| Insulin resistance in hidradenitis suppurativa: a case-control study |
18 |
| Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board |
17 |
| Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study |
17 |
| Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice |
16 |
| European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period |
16 |
| Immune response patterns in non-communicable inflammatory skin diseases |
16 |
| Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre |
16 |
| Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion |
16 |
| Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the << OBJECTIFS PEAU >> study |
16 |
| Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis |
15 |
| JAK inhibitors for alopecia areata: a systematic review and meta-analysis |
15 |
| Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients |
15 |
| Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study |
15 |
| Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study |
15 |
| Defining the actinic keratosis field: a literature review and discussion |
15 |
| The impact of airborne pollution on skin |
15 |
| Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis |
15 |
| Generalized pustular psoriasis: a review and update on treatment |
14 |
| Position statement for the management of comorbidities in psoriasis |
13 |
| Microneedling for the treatment of hair loss? |
13 |
| Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study |
13 |
| Dermoscopy vs. reflectance confocal microscopy for the diagnosis of lentigo maligna |
13 |
| Problems and challenges of predatory journals |
12 |
| Different outdoor professions have different risks - a cross-sectional study comparing non-melanoma skin cancer risk among farmers, gardeners and mountain guides |
12 |
| Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study |
12 |
| The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries |
12 |
| Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre |
12 |
| Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases |
12 |
| Primary prevention of keratinocyte carcinoma among outdoor workers, the general population and medical professionals: a systematic review updated for 2019 |
12 |
| Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures |
12 |
| Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature |
12 |
| Skin diseases are more common than we think: screening results of an unreferred population at the Munich Oktoberfest |
12 |
